Function and Biogenesis of Lipopolysaccharides
Overview
Authors
Affiliations
The cell envelope is the first line of defense between a bacterium and the world-at-large. Often, the initial steps that determine the outcome of chemical warfare, bacteriophage infections, and battles with other bacteria or the immune system greatly depend on the structure and composition of the bacterial cell surface. One of the most studied bacterial surface molecules is the glycolipid known as lipopolysaccharide (LPS), which is produced by most Gram-negative bacteria. Much of the initial attention LPS received in the early 1900s was owed to its ability to stimulate the immune system, for which the glycolipid was commonly known as endotoxin. It was later discovered that LPS also creates a permeability barrier at the cell surface and is a main contributor to the innate resistance that Gram-negative bacteria display against many antimicrobials. Not surprisingly, these important properties of LPS have driven a vast and still prolific body of literature for more than a hundred years. LPS research has also led to pioneering studies in bacterial envelope biogenesis and physiology, mostly using and as model systems. In this review, we will focus on the fundamental knowledge we have gained from studies of the complex structure of the LPS molecule and the biochemical pathways for its synthesis, as well as the transport of LPS across the bacterial envelope and its assembly at the cell surface.
Determining the LPS structural features that influence TLR4 downstream signaling.
Manivannan K, Fathy Mohamed Y, Fernandez R Front Microbiol. 2025; 16:1540534.
PMID: 40071202 PMC: 11895810. DOI: 10.3389/fmicb.2025.1540534.
Jandosov J, Berillo D, Misra A, Alavijeh M, Chenchik D, Baimenov A Int J Mol Sci. 2025; 26(3).
PMID: 39940720 PMC: 11817206. DOI: 10.3390/ijms26030952.
Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses.
Sardar P, Beresford-Jones B, Xia W, Shabana O, Suyama S, Ramos R Nat Microbiol. 2025; 10(3):795-807.
PMID: 39929976 PMC: 11879847. DOI: 10.1038/s41564-025-01930-y.
Identifying Opportunity Targets in Gram-Negative Pathogens for Infectious Disease Mitigation.
Paddy I, Dassama L ACS Cent Sci. 2025; 11(1):25-35.
PMID: 39866699 PMC: 11758222. DOI: 10.1021/acscentsci.4c01437.
Airborne Escherichia coli bacteria biosynthesize lipids in response to aerosolization stress.
Smith B, Zhang M, King M Sci Rep. 2025; 15(1):2349.
PMID: 39833243 PMC: 11746921. DOI: 10.1038/s41598-025-86562-2.